Team

Strategic Advisors

Deborah Ancona, PhD
Seley Distinguished Professor of Management; Professor of Organization Studies; Faculty Director, MIT Leadership Center, MIT Sloan School of Management
Retsef Levi, PhD
J. Spencer Standish (1945) Professor of Management; Associate Professor of Operations Management, MIT Sloan School of Management
Denny A. Ausiello, MD
CATCH Co-Founder, Director; Jackson Professor of Clinical Medicine, Harvard Medical School; Chief of Medicine, MGH; Director, Pfizer
Andrew Lo, PhD
Charles E. and Susan T. Harris Professor of Finance; Director, Laboratory for Financial Engineering, MIT Sloan School of Management
Ernest Berndt, PhD, MS
Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program
Alex 'Sandy' Pentland, PhD
Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program
Charles L. Cooney, PhD
Robert T. Haslam Professor of Chemical Engineering, MIT; Faculty Director, Deshpande Center for Technological Innovation
Ram Sasisekharan, PhD
Director, Harvard – MIT Health Sciences and Technology, Edward Hood Taplin Professor of Health Sciences & Technology and Biological Engineering, MIT
Michael A. Cusumano, PhD
Sloan Management Review Distinguished Professor of Management, MIT Sloan School of Management
Phillip A. Sharp, PhD
Institute Professor, Koch Institute for Integrative Cancer Research, MIT
Elazer Edelman, MD, PhD, FACC
Thomas D & Virginia W Cabot Professor of HST, Health Sciences and Technology Program, MIT
Anthony Sinskey, ScD
Faculty Director, CBI; Professor of Biology and Health Sciences and Technology, MIT

Executive Committee

The Executive Committee for NEWDIGS is an advisory body, which meets once a quarter throughout the calendar year. The role of the Executive Committee is to contribute ideas for projects, vet new opportunities, and disseminate emerging insights and recommendations from NEWDIGS activities The Executive Committee will assist with outreach to potential sponsors and endorse the goals of NEWDIGS projects as well the alignment of new projects with NEWDIGS mission and priorities; It has no financial or fiduciary responsibility, nor does it make any product-specific decisions. Typical agenda items include research updates, workshop opportunities, new mini-consortia proposals and pending publications.

Elizabeth Cobbs, PhD
Head, Medical Policy & Quality Research Merck & Co. Inc.
Hilary M. Malone, PhD
Chief Regulatory Officer, Head of Global Regulatory Affairs Sanofi
Nick Crabb, PhD
Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE)
Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Anne-Virginie Eggimann, MSc
Vice President, Regulatory Science bluebird bio
Peter Saltonsall
President and CEO National Organization for Rare Disorders (NORD)
Hans-Georg Eichler, MD, MSc
Senior Medical Officer European Medicines Agency
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS

Affiliated Faculty and Researchers

Jane F. Barlow, MD, MPH, MBA
Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates
Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Ernest Berndt, PhD, MS
Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program
Nitin R. Patel, PhD
Research Affiliate, MIT Center for Biomedical Innovation; Founder, Chairman, and Chief Technology Officer, Cytel Statistical Software and Services
Jeff Brown, PhD
Assistant Professor, Department of Population Medicine, Harvard Medical School
Casey Quinn, PhD
Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Chester Drum, MD, PhD
Assistant Professor, Department of Medicine, National University of Singapore
G.K. Raju, PhD
CBI Distinguished Fellow; Chairman, CBI Biomanufacturing Steering Committee; Executive Director, MIT Pharmaceutical Manufacturing Initiative
R. John Glasspool
Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
J. Russell Teagarden, DMH, MA
Senior Health Care Practitioner, Independent Advisor, Researcher and Writer; Financing and Reimbursement of Cures in the US (FoCUS) Project
Donald Han, BSc Pharm
Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Judy Maro, PhD, MS
Research Affiliate, Center for Biomedical Innovation, Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute

NEWDIGS Staff

David P. Fritsche, MBA
dpfritsc@mit.edu
Technology Officer, Learning Ecosystems for Accelerating Patient-centered & Sustainable (LEAPS) Innovation Project
617-324-7763
Katie Torrence
ktorrenc@mit.edu
Project Coordinator, Financing and Reimbursement of Cures in the US (FoCUS)
617-324-2695
Gigi Hirsch, M.D.
ghirsch@mit.edu
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS
617-253-9609
Mark Trusheim, MSc
trusheim@mit.edu
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Kay Larholt, ScD
klarholt@mit.edu
Director of Integrated Knowledge Solutions
617-253-7333
Mo Yang, PhD
moyang@mit.edu
Health Economics and Financing Research Lead, Financing and Reimbursement of Cures in the US (FoCUS) Program
617-324-2695
Daniel Mytelka, PhD, MBA, CFA
mytelka@mit.edu
Director, Simulation & Policy Research, Financing and Reimbursement of Cures in the US (FoCUS)
Deborah L. Young, EMBA, Ed.M.
debyoung@mit.edu
Director of Operations, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
617-324-7756
Kelly Necastro, MPH
kneca@mit.edu
Project Coordinator, Learning Ecosystems for Accelerating Patient-centered & Sustainable (LEAPS) Innovation Project
617-324-7763
Colin Young, PhD
colyoung@mit.edu
Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS)
617-324-7261
Eric A. Small
easmall@mit.edu
Administrative Assistant II, NEWDIGS; Assistant to Executive Director Gigi Hirsch
617-324-4841

FoCUS Project Team

Financing and Reimbursement of Cures in the U.S.

Jane F. Barlow, MD, MPH, MBA
Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates
J. Russell Teagarden, DMH, MA
Senior Health Care Practitioner, Independent Advisor, Researcher and Writer; Financing and Reimbursement of Cures in the US (FoCUS) Project
R. John Glasspool
Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Katie Torrence
Project Coordinator, Financing and Reimbursement of Cures in the US (FoCUS)
617-324-2695
Donald Han, BSc Pharm
Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS
617-253-9609
Mo Yang, PhD
Health Economics and Financing Research Lead, Financing and Reimbursement of Cures in the US (FoCUS) Program
617-324-2695
Daniel Mytelka, PhD, MBA, CFA
Director, Simulation & Policy Research, Financing and Reimbursement of Cures in the US (FoCUS)
Colin Young, PhD
Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS)
617-324-7261
Casey Quinn, PhD
Research Affiliate, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Deborah L. Young, EMBA, Ed.M.
Director of Operations, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
617-324-7756

LEAPS Project Team

David P. Fritsche, MBA
Technology Officer, Learning Ecosystems for Accelerating Patient-centered & Sustainable (LEAPS) Innovation Project
617-324-7763
Kelly Necastro, MPH
Project Coordinator, Learning Ecosystems for Accelerating Patient-centered & Sustainable (LEAPS) Innovation Project
617-324-7763
Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS
617-253-9609
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Kay Larholt, ScD
Director of Integrated Knowledge Solutions
617-253-7333

Strategic Advisory Network

Anna D. Barker, PhD
Co-Director, Complex Adaptive Systems (CAS); Director, National Biomarker Development Alliance (NBDA); Professor, School of Life Sciences, Arizona State University (ASU)
Secretary Marylou Sudders, MS, Hon.DSc
Secretary of Health and Human Services, Commonwealth of Massachusetts
Alex 'Sandy' Pentland, PhD
Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program
Susan Windham-Bannister, PhD
President & CEO, Biomedical Growth Strategies LLC; Managing Partner, Biomedical Innovation Advisors LLC
Michael S. Sherman, MD, MBA, MS, CPE
Senior Vice President & Chief Medical Officer; Harvard Pilgrim Health Care
Janet Woodcock, MD
Director, Center for Drug Evaluation and Research, US Food and Drug Administration